The PennZone

  • Home
  • Business
  • Health
  • Construction
  • Real Estate
  • Technology
  • Travel
  • Legal
  • Music

Utah attempts to legalize placenta cell therapy
The PennZone/10266985

Trending...
  • Cancun Airport Transportation Expands Fleet Ahead of Record Passenger Growth at Cancun International Airport
  • Hope Survives Launches The Hope Collective, A Curated Publication Centering Lived Experience After Brain Injury
  • Claude Riveloux Review 2026: How the $10B Fund Manager Dispels 'Scam' Rumors Through Education
Parent's Guide to Cord Blood Foundation
Exclusive: How a small group of patient advocates and biotech companies tricked the Utah legislature into passing a law which sets a precedent. Utah is now the first state to legalize therapy with stem cells from placenta tissue and cord blood.

BROOKEVILLE, Md. - PennZone -- Exclusive: How a small group of patient advocates and biotech companies tricked the Utah legislature into passing a law which sets a precedent. Utah is now the first state to legalize therapy with stem cells from placenta tissue and cord blood.

Parent's Guide to Cord Blood Foundation is a small non-profit in the biotech space. We are the first to break the story that the Utah state legislature did not realize what they were voting for when they passed Utah S.B. 199.

More on The PennZone
  • South Philadelphia Filmmakers Launch Fourth Feature Film on Amazon Prime Video
  • Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA
  • 46th International Symposium On Forecasting – Dates, Venue And Speakers Announced
  • Phoenix Rebellion Therapy Celebrates 10 Years Helping Utahns Overcome Trauma as Utah Faces Nation's 2nd-Highest Rate of Mental Health Challenges
  • Bonavita Luxury & Portable Lavatories Announces Rebrand to Bonavita Site Solutions

The FDA still considers unapproved stem cell therapies to be illegal, and when it comes to drug regulations, federal law takes supremacy. This is not the same as states ignoring federal law and legalizing recreational drugs. In the case of stem cell therapy, patients that receive unregulated products with insufficient oversight could suffer serious adverse events. The new law Utah S.B. 199 is going to trigger a showdown between the federal government and Utah. Doctors who administer therapy to patients under the new Utah law could be sued by the Dept. of Justice. At a bare minimum, we are calling for the state of Utah to establish oversight of this arena before patients are hurt.

Contact
Frances Verter, PhD
***@parentsguidecordblood.org


Source: Parent's Guide to Cord Blood Foundation

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Elder Abuse Case Against Healthy Traditions Owner Raises Questions As To The Dire Reality Of Abuse Against The Last Of The Baby Boomers
  • Integrative Psychiatry of America Expands Access to Telehealth Mental Health Care in Pennsylvania
  • Simpalm Staffing Services Launched its Refreshed Website for Remote Staffing Services
  • Claude Riveloux Review 2026: How the $10B Fund Manager Dispels 'Scam' Rumors Through Education
  • Pure Energy Electrical Services, LLC Announces Strong Start to 2026, Reinforcing Customer-First Electrical Service Across Northeast Florida
  • Danholm Collection Launches Boutique Luxury Real Estate Brokerage in Central Florida
  • Cordially Clean Introduces Premium, Reliable Cleaning Services Focused on Professionalism and Care
  • Sellvia Market Expands Curated Store Portfolio for Dropshipping Sellers
  • Food Journal Magazine Raises the Standard for Restaurant Reviews in Los Angeles
  • Mike "The Situation" Sorrentino Announces His Latest Venture with Rinia HRT Franchising, LLC as Co-Owner
  • Exeter Smiles in Allentown Is Now Accepting New Patients for Affordable Braces and Invisalign
  • Williamsville Spa Expands Team to Meet Growing Demand for Professional Facials
  • Pregis Expands Wind Energy Use, Advancing Progress Toward Net Zero by 2040
  • Dr. Sheel Desai Solomon and Preston Dermatology Continue Awards Streak with Top Honors in 2026 Maggy Awards
  • Jack and Sage Acquires Sustainable Apparel Brand Kastlfel, Expanding Premium Logo Wear Across National Parks and Ski Resorts
  • York Entrepreneur Launches AI Training to Help Small Businesses Navigate the AI Revolution
  • Cancun International Airport Prepares for Record Travel Surge Ahead of Spring Break, Summer, and the 2026 High Season
  • $167 Billion Pharma R&D Market Largely Untapped by AI Creates Major Growth Runway for KALA Bios Data-Sovereign AI Strategy: N A S D A Q: KALA
  • Lighthouse Tech Awards Recognize Top HR Technology Providers for 2026
  • ADB Selects OneVizion to Advance Field Execution and Infrastructure Program Management

Popular on PennZone

  • OneVizion Announces Next Phase of Growth as Brad Kitchens Joins Board of Directors - 125
  • Still Using Ice? FrostSkin Reinvents Hydration - 106
  • Cold. Clean. Anywhere. Meet FrostSkin
  • Ice Melts. Infrastructure Fails. What Happens to Clean Water?
  • Mend Colorado Launches Revamped Sports Performance Training Page
  • Deep Learning Robotics (DLRob) Announces Pre-Launch of Zero-Teach and Teach-by-Demonstration Technology for Kitting Applications
  • The Legal AI Showdown: Westlaw, Lexis, ChatGPT… or EvenSteven?
  • Northwest Modern Fabrication Expands Manufacturing Capacity With 4,800 Sq. Ft. Addition
  • From Coffee to Commutes: sMiles App Now Pays Bitcoin for Every Gift Card Purchase
  • TL International Group Becomes First Global Operator to Fully Migrate to Pulsant's Dedicated Car Rental Cloud

Similar on PennZone

  • Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA
  • $167 Billion Pharma R&D Market Largely Untapped by AI Creates Major Growth Runway for KALA Bios Data-Sovereign AI Strategy: N A S D A Q: KALA
  • National Expansion Ignited Across Amazon $AMZN, Chewy $CHWY & Walmart $WMT: NDT Pharmaceuticals, Inc. (Stock Symbol: NDTP) $NDTP
  • Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
  • Postmortem Pathology Expands Independent Autopsy Services in Kansas City
  • ClearSight Therapeutics Signs LOI with Covalent Medical for $60M Multi-Channel OTC Eye Care Partnership
  • Capsadyn® Launches on Amazon, Offering Non-Burning Capsaicin Pain Relief
  • FDA Meeting Indicates a pivotal development that could redefine the treatment landscape for suicidal depression via NRx Pharmaceuticals: $NRXP
  • Parkway Prosthodontics Achieves Breakthrough Full-Arch Reconstruction Case
  • Postmortem Pathology Expands to Phoenix: Bringing Families Answers During Their Most Difficult Moments
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us